As the global demand for safe and cost-effective anticoagulants keeps
rising, Enoxaparin Sodium, a leading low molecular weight heparin (LMWH), has
become indispensable in clinical practice—widely used for preventing deep vein
thrombosis, treating pulmonary embolism, and managing acute coronary syndromes. With the global Enoxaparin Sodium market
expanding steadily and strict regulatory requirements for product purity and
safety, pharmaceutical partners worldwide are seeking a reliable supplier that
combines innovative technology, green production, and regional compliance.
Jiulong, a leading biopharmaceutical manufacturer with rich experience in
heparin derivatives, stands out with its improved preparation process and green
manufacturing solutions, addressing industry pain points of low yield, solvent
residue, and high production costs while delivering high-quality Enoxaparin
Sodium to global markets.
What makes Jiulong a trusted supplier of Enoxaparin Sodium is its
proprietary improved preparation process, designed to overcome the limitations
of traditional production methods. Unlike conventional processes that suffer
from low yield, heavy solvent use, and operational difficulties in isolating
intermediate products, Jiulong adopts a
gradient ultrafiltration and nanofiltration integration technology, replacing
complex and costly chromatographic separation. This advanced process optimizes
benzyl esterification and alkaline depolymerization steps, reducing organic
solvent usage by 30% and increasing product yield by 18% compared to industry
averages. It ensures Enoxaparin Sodium meets strict molecular
weight distribution requirements (3000–8000 Da), with a purity of over 99% and a
stable anti-Xa/anti-IIa ratio of 3.3–5.3, fully complying with USP, EP, and ChP
pharmacopeial standards.

As a global supplier of Enoxaparin Sodium, Jiulong integrates green
manufacturing into every production link, aligning with global environmental
sustainability goals and regional green regulatory trends. We adopt a
closed-loop solvent recovery system to recycle and reuse organic solvents,
minimizing environmental pollution and reducing production costs. Additionally, our low-temperature freeze-drying
process, optimized with nitrogen protection, preserves the native molecular
structure of Enoxaparin Sodium, ensuring high bioactivity and fast
reconstitution speed, while avoiding thermal degradation common in traditional
high-temperature drying. This green and efficient production
mode not only enhances product competitiveness but also helps partners meet
regional environmental compliance requirements.
Jiulong’s competitive edge in Enoxaparin Sodium supply also lies in its
strict quality control and seamless regional regulatory compliance. We source
high-quality porcine intestinal heparin from legal, traceable suppliers, mitigating risks of raw material contamination and shortage.
Every batch of Enoxaparin Sodium undergoes rigorous testing, including molecular
weight analysis, anti-Xa/anti-IIa activity detection, and solvent residue
inspection, guaranteeing safety and consistency. For global
partners, we provide tailored compliance support: FDA cGMP compliance for North
America, EMA and EDQM certification support for Europe, and NMPA compliance for
the Asia-Pacific market, ensuring smooth market access.
As the global Enoxaparin Sodium market evolves, with growing demand for
generic versions and green pharmaceuticals,
Jiulong remains committed to innovation. Our ongoing R&D focuses on further
optimizing the preparation process to reduce costs and enhance product
stability, while expanding our supply capacity to meet the rising global demand.
Backed by decades of heparin manufacturing expertise, strict quality control,
and a global sales network, Jiulong has established itself as a reliable
supplier of Enoxaparin Sodium for pharmaceutical companies, hospitals, and
healthcare providers worldwide.
Ready to source high-yield, green, and regulatory-compliant Enoxaparin
Sodium? Contact Jiulong today to discuss your specific requirements, request
samples, or learn how our improved preparation process can elevate your
anticoagulant products and support your success in the global market.